Approval · Notice of Compliance 1339 · 2000
NEGGRAM: Notice of Compliance 1339
Issued November 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1339
- Date
- November 1, 2000
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Urinary antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEGGRAM | 02017687 | Cancelled Post Market |
Medicinal ingredients
- NALIDIXIC ACID 500 MG per TAB